Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: Involvement of nuclear factor kappa B, Bax and Bcl-2

Journal of Pineal Research

Volumn 41, Issue 2, 2006, Pages 116-123

  Chetsawang, Banthit ^a   Putthaprasart, Chorkaew ^a   Phansuwan Pujito, Pansiri ^b   Govitrapong, Piyarat ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLASPARTYLGLUTAMYLVALYLASPARTIC ACID; CASPASE INHIBITOR; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NERVE CELL DEGENERATION; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL DEATH; CELL LINE, TUMOR; HUMANS; HYDROGEN PEROXIDE; MELATONIN; NEURONS; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 33746504821     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00335.x     Document Type: Article

References (45)

1. CASSARINO DS, BENNETT JP, Jr. An evaluation of the role of mitochondria in neurodegenerative disease: mitochondrial mutations and oxidative pathology, protective nuclear response, and cell death in neurodegeneration. Brain Res Rev 1999; 29:1-25.
2. FRIEDLANDER RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003; 348:1365-1375.
3. NISHIDA S, SATO R, MURAI I et al. Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats. J Pineal Res 2003; 35:251-256.
4. PAGE-MCCAW PS, CHUNG SC, MUTO A et al. Retinal network adaptation to bright light requires tyrosinase. Nat Neurosci 2004; 7:1329-1336.
5. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
6. MEKI AR, ESMAIL EEL D, HUSSEIN AA et al. Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: effect of melatonin. Toxicon 2004; 43:93-100.
7. +-induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 2005; 39:34-42.
8. BLUM D, TORCH S, LAMBENG N et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001; 65:135-172.
9. FISKUM G. Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 2000; 17:843-855.
10. CHAN PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21:2-14.
11. MULLER JM, RUPEC RA, BAEUERLE PA. Study of gene regulation by NF-kappa B and AP-1 in response to reactive oxygen intermediates. Methods 1997; 11:301-312.
12. MARTINDALE JL, HOLBROOK NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 2002; 192:1-15.
13. BENI SM, KOHEN R, REITER RJ et al. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004; 18:149-151.
14. BAEUERLE PA, HENKEL T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-179.
15. CHEN F, SHI X. Signaling from toxic metals to NF-kappaB and beyond: not just a matter of reactive oxygen species. Environ Health Perspect 2002; 110:807-811.
16. CULMSEE C, MATTSON MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun 2005; 331:761-777.
17. REED JC. Bcl-2 family proteins. Oncogene 1998; 17:3225-3236.
18. JUKNAT AA, MENDEZ MDEL V, QUAGLINO A et al. Melatonin prevents hydrogen peroxide-induced Bax expression in cultured rat astrocytes. J Pineal Res 2005; 38:84-92.
19. SORG O. Oxidative stress: a theoretical model or a biological reality? C R Biol 2004; 327:649-662.
20. GILGUN-SHERKI Y, ROSENBAUM Z, MELAMED E et al. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 2002; 54:271-284.
21. ISCHIROPOULOS H, BECKMAN JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 2003; 111:163-169.
22. FAHN S, COHEN G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992; 32:804-812.
23. 2), caspase-3, and nuclear factor kappa-B (NF-kappaB), p53, c-Jun transcription factors. Biochem Pharmacol 2002; 63:677-688.
24. OSSENI RA, RAT P, BOGDAN A et al. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000; 68:387-399.
25. TAN DX, MANCHESTER LC, REITER RJ et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000; 29:1177-1185.
26. RODRIGUEZ C, MAYO JC, SAINZ RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36:1-9.
27. TOMAS-ZAPICO C, COTO-MONTES A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39:99-104.
28. GARCIA JJ, REITER RJ, PIE J et al. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr 1999; 31:609-616.
29. TAN DX, HARDELAND R, MANCHESTER LC et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003; 34:249-259.
30. SILVA SO, RODRIGUES MR, CARVALHO SR et al. Oxidation of melatonin and its catabolites, N1-acetyl-N2-formyl-5-methoxykynuramine and N1-acetyl-5- methoxykynuramine, by activated leukocytes. J Pineal Res 2004; 37:171-175.
31. ONUKI J, ALMEIDA EA, MEDEIROS MH et al. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005; 38:107-115.
32. GUENTHER AL, SCHMIDT SI, LAATSCH H et al. Reaction of the melatonin metabolite AMK (N1-acrtyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compound, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005; 39:251-260.
33. BALDWIN AS, Jr. The NF-κB and IkB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-681.
34. LIU ZG. Molecular mechanism of TNF signaling and beyond. Cell Res 2005; 15:24-27.
35. SCHMITZ ML, MATTIOLI I, BUSS H et al. NF-kappaB: a multifaceted transcription factor regulated at several levels. Chembiochem 2004; 5:1348-1358.
36. CRACK PJ, TAYLOR JM. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med 2005; 38:1433-1444.
37. UBERTI D, CARSANA T, FRANCISCONI S et al. A novel mechanism for pergolide-induced neuroprotection: inhibition of NF-kappaB nuclear translocation. Biochem Pharmacol 2004; 67:1743-1750.
38. WU KK. Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostaglandins Leukot Essent Fatty Acids 2005; 72:89-93.
39. TRUBIANI O, SALVOLINI E, VIGNINI A et al. NF-kappaB and NOS may play a role in human RPMI-8402 cell apoptosis. Cell Biol Int 2005; 29:529-536.
40. BRUCK R, AEED H, AVNI Y et al. Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in rats. J Hepatol 2004; 40:86-93.
41. KORSMEYER SJ. Bcl-2 gene family and the regulation of programmed cell death. Cancer Res Suppl 1999; 59:1693-1700.
42. JANG MH, JUNG SB, LEE MH et al. Melatonin attenuates amyloid beta25-35-induced apoptosis in mouse microglial BV2 cells. Neurosci Lett 2005; 380:26-31.
43. LI P, NIJHAWAN D, BUDIHARDJO I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489.
44. LOPEZ E, FERRER I. Staurosporine- and H-7-induced cell death in SH-SY5Y neuroblastoma cells is associated with caspase-2 and caspase-3 activation, but not with activation of the FAS/FAS-L-caspase-8 signaling pathway. Brain Res Mol Brain Res 2000; 85:61-67.
45. JOU MJ, PENG TI, REITER RJ et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37:55-70.